Serial Number
88829932
Owner
SAREPTA THERAPEUTICS, INC.Attorney
Paul C. LlewellynFirst Use Date
Sep 19, 2016
Filing Date
Mar 11, 2020
Serial #88829932 Trademark
Serial Number: 88829932 • Registration: 6918743
Trademark Classes
Owner Contact Info
215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
March 11, 2020
Registration Date
December 6, 2022
First Use Anywhere
September 19, 2016
First Use in Commerce
September 19, 2016
Published for Opposition
July 21, 2020
Goods & Services
pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
